← Back to News

Jim Cramer Comments On Boston Scientific and Other Medical Equipment Makers

neutralAnalyst ratingMulti dayYahoo Finance ·1 Jun 2026Original article ↗
Oraklio AI Analysis

This is commentary/television advice rather than new company fundamentals, but it can influence near-term sentiment and positioning, especially since BSX was explicitly discussed alongside recent/ongoing performance and relative peer comparisons.

Article

Jim Cramer Comments On Boston Scientific and Other Medical Equipment Makers Syeda Seirut Javed Mon, June 1, 2026 at 7:53 PM GMT+2 2 min read BSX MDT ABT Boston Scientific Corporation (NYSE: BSX ) was among the stocks Jim Cramer was focused on, as he discussed Mad Money’s latest game plan for the week . An Investing Club member sought Cramer’s advice about choosing the best medical equipment maker out of the three: Abbott Labs, Boston Scientific, and Medtronic. He replied: Boston Scientific had a very weak quarter because its primary product did not do well.

Abbott Labs bought this Exact Sciences; I don’t know exactly what it’s going to look like. Medtronic has fallen off a cliff, and they report next week. Let’s look at Medtronic after they report, and then that may be the one that we pull the trigger on.

Photo by Artem Podrez on Pexels Boston Scientific Corporation (NYSE:BSX) manufactures medical devices for different fields, including cardiology, neurology, and urology. Some of the company’s products include heart-monitoring implants, spinal cord stimulators, and diagnostic tools for gastrointestinal conditions and cancer treatment. During the May 11 episode, a caller asked if they should sell or buy more of the company shares.

Cramer replied: I hate to sell these. I don’t mean to sound wishy-washy, but I think you gotta hold it. I don’t understand how this thing could have fallen so fast.

I know there’s a lot of competition. I don’t want to dump it here, but I can’t, I can’t countenance buying more, I’m sorry. While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk.

If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock . READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years   Disclosure: None. Follow Insider Monkey on Google News .

Oraklio AI Trading Intelligence

News is just the start.

Oraklio turns news, price data, and market signals into structured BUY / SELL / NO_TRADE calls - updated continuously throughout the trading day.

Get started free

Already have an account? Sign in →